Recurrent stroke is common immediately following a transient ischemic attack (TIA) or
ischemic stroke. Dual antiplatelet therapy (DAPT) with clopidogrel and aspirin may provide …

Background and purpose Dual antiplatelet therapy (DAPT) with aspirin and clopidogrel for
90 days was recommended as the secondary prevention of minor ischaemic strokes or …

Background: In patients with acute minor ischemic stroke or high-risk transient ischemic
attack enrolled in the POINT trial (Platelet-Oriented Inhibition in New TIA and Minor Ischemic …

Background: Antiplatelet agents are the mainstay for secondary prevention of non-
cardioembolic stroke. This systematic review examined the safety and efficacy of short …

Background Combination antiplatelet therapy with clopidogrel and aspirin may reduce the
rate of recurrent stroke during the first 3 months after a minor ischemic stroke or transient …

Aim. Though combination of clopidogrel added to aspirin has been compared to aspirin
alone in patients with stroke or transient ischemic attack, limited data exists on the relative …

Purpose The safety and efficacy of dual antiplatelet therapy (DAPT) with aspirin and
clopidogrel in the setting of secondary stroke prevention are reviewed. Summary Antiplatelet …

Background Clopidogrel was superior to aspirin in patients with previous manifestations of
atherothrombotic disease in the CAPRIE study and its benefit was amplified in some high …

Background and Purpose—The role of aspirin plus clopidogrel (A+ C) therapy compared
with aspirin monotherapy in patients presenting with acute ischemic stroke (IS) or transient …

Objective: Patients experiencing acute ischemic stroke or transient ischemic attack are
commonly treated with clopidogrel and/or aspirin (mono-and dual-antiplatelet therapy) to …